S&P assigns ‘AA/A-1+’ rating to Mayo Clinic’s bonds

Standard & Poor’s Ratings Services has assigned an “AA/A-1+” rating to Rochester, Minn.-based Mayo Clinic’s series 2016 revenue bonds, affecting $75 million.

Advertisement

S&P also affirmed its outstanding long- and short-term ratings on debt issued for Mayo Clinic directly and through various issuers.

“The long-term rating on the Mayo Clinic reflects an excellent enterprise profile as one of the country’s leading health systems,” said S&P credit analyst Martin Arrick.

The outlook is stable, reflecting S&P’s view that Mayo Clinic’s sound financial profile is sustainable over the two-year outlook period.

More articles on healthcare finance:
Michigan hospital set to lose Medicare status over patient suicide 
This week’s 5 must-reads for hospital CFOs 
8 healthcare CFOs in the headlines 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.